Saudi Pharmaceutical Industries and Medical Appliances Corp. (SPIMACO) posted a 32 percent year-on-year (YoY) fall in net profit after zakat and tax to SAR 100.8 million for fiscal year 2018. The annual figures were hit by lower sales revenue from the Saudi private sector and exports to some countries.
A decline in the gross profit of SPIMACO’s affiliate, which provides healthcare services as well as higher financing charges also weighed negatively on FY 2018 net profit.
In addition, an associate widened impairment losses in the same period.
Item | 2017 | 2018 | Change |
---|---|---|---|
Revenues | 1,386.04 | 1,503.32 | 8.5 % |
Gross Income | 704.46 | 608.52 | (13.6 %) |
Operating Income | 166.33 | 21.00 | (87.4 %) |
Net Income | 197.37 | 76.58 | (61.2 %) |
Average Shares | 120.00 | 120.00 | - |
EPS (Riyals) | 1.64 | 0.64 | (61.2 %) |
Item | Q4 2017 | Q4 2018 | Change |
---|---|---|---|
Revenues | 410.69 | 600.79 | 46.3 % |
Gross Income | 207.07 | 127.79 | (38.3 %) |
Operating Income | 58.60 | (48.39) | (182.6 %) |
Net Income | 66.61 | 19.01 | (71.5 %) |
Average Shares | 120.00 | 120.00 | - |
EPS (Riyals) | 0.56 | 0.16 | (71.5 %) |
Item | Q3 2018 | Q4 2018 | Change |
---|---|---|---|
Revenues | 224.95 | 600.79 | 167.1 % |
Gross Income | 137.89 | 127.79 | (7.3 %) |
Operating Income | 3.59 | (48.39) | (1447.9 %) |
Net Income | (12.12) | 19.01 | 256.9 % |
Average Shares | 120.00 | 120.00 | - |
EPS (Riyals) | (0.10) | 0.16 | 256.9 % |
Period | Revenues | Change | Gross Income | Change | Net Income | Change | EPS(Riyal) |
---|---|---|---|---|---|---|---|
Q1 2009 | 257.88 | 16.9 % | 108.57 | 9.0 % | 42.69 | 4.3 % | 0.42 |
Q2 2009 | 229.00 | 8.2 % | 81.53 | 9.0 % | 37.81 | 10.4 % | 0.37 |
Q3 2009 | 171.15 | 17.7 % | 72.49 | (2.5 %) | 15.84 | 1.4 % | 0.16 |
Q4 2009 | 292.71 | (0.5 %) | 157.00 | 37.4 % | 58.48 | 56.0 % | 0.58 |
2009 | 950.74 | 9.0 % | 419.59 | 15.6 % | 154.81 | 20.7 % | 1.53 |
Q1 2010 | 274.33 | 6.4 % | 118.90 | 9.5 % | 45.32 | 6.2 % | 0.38 |
Q2 2010 | 252.34 | 10.2 % | 100.50 | 23.3 % | 43.09 | 14.0 % | 0.36 |
Q3 2010 | 191.40 | 11.8 % | 85.88 | 18.5 % | 18.07 | 14.1 % | 0.15 |
Q4 2010 | 319.57 | 9.2 % | 181.12 | 15.4 % | 70.04 | 19.8 % | 0.58 |
2010 | 1,037.64 | 9.1 % | 486.40 | 15.9 % | 176.52 | 14.0 % | 1.47 |
Q1 2011 | 252.08 | (8.1 %) | 123.51 | 3.9 % | 45.71 | 0.9 % | 0.38 |
Q2 2011 | 292.08 | 15.7 % | 123.61 | 23.0 % | 60.75 | 41.0 % | 0.51 |
Q3 2011 | 209.24 | 9.3 % | 106.76 | 24.3 % | 29.75 | 64.6 % | 0.25 |
Q4 2011 | 375.82 | 17.6 % | 206.69 | 14.1 % | 74.06 | 5.7 % | 0.62 |
2011 | 1,129.22 | 8.8 % | 560.57 | 15.2 % | 211.44 | 19.8 % | 1.76 |
Q1 2012 | 303.14 | 20.3 % | 153.21 | 24.0 % | 56.45 | 23.5 % | 0.47 |
Q2 2012 | 286.64 | (1.9 %) | 140.91 | 14.0 % | 90.14 | 48.4 % | 0.75 |
Q3 2012 | 227.40 | 8.7 % | 113.28 | 6.1 % | 32.33 | 8.7 % | 0.27 |
Q4 2012 | 365.97 | (2.6 %) | 211.16 | 2.2 % | 53.73 | (27.5 %) | 0.45 |
2012 | 1,183.15 | 4.8 % | 618.56 | 10.3 % | 232.65 | 10.0 % | 1.94 |
Q1 2013 | 361.37 | 19.2 % | 184.62 | 20.5 % | 63.15 | 11.9 % | 0.53 |
Q2 2013 | 344.22 | 20.1 % | 179.12 | 27.1 % | 113.71 | 26.1 % | 0.95 |
Q3 2013 | 222.91 | (2.0 %) | 118.64 | 4.7 % | 34.19 | 5.8 % | 0.28 |
Q4 2013 | 382.01 | 4.4 % | 226.14 | 7.1 % | 57.01 | 6.1 % | 0.48 |
2013 | 1,310.50 | 10.8 % | 708.52 | 14.5 % | 266.82 | 14.7 % | 2.22 |
Q1 2014 | 405.21 | 12.1 % | 206.72 | 12.0 % | 91.17 | 44.4 % | 0.76 |
Q2 2014 | 371.14 | 7.8 % | 193.14 | 7.8 % | 97.72 | (14.1 %) | 0.81 |
Q3 2014 | 266.02 | 19.3 % | 134.45 | 13.3 % | 36.69 | 7.3 % | 0.31 |
Q4 2014 | 431.06 | 12.8 % | 261.80 | 15.8 % | 91.29 | 60.1 % | 0.76 |
2014 | 1,470.19 | 12.2 % | 794.54 | 12.1 % | 316.85 | 18.8 % | 2.64 |
Q1 2015 | 432.20 | 6.7 % | 225.86 | 9.3 % | 99.39 | 9.0 % | 0.83 |
Q2 2015 | 435.80 | 17.4 % | 210.95 | 9.2 % | 237.63 | 143.2 % | 1.98 |
Q3 2015 | 308.27 | 15.9 % | 131.32 | (2.3 %) | 29.16 | (20.5 %) | 0.24 |
Q4 2015 | 520.38 | 20.7 % | 266.38 | 1.7 % | (9.12) | (110.0 %) | (0.08) |
2015 | 1,705.05 | 16.0 % | 848.60 | 6.8 % | 357.05 | 12.7 % | 2.98 |
Q1 2016 | 322.20 | (25.4 %) | 194.26 | (14.0 %) | 88.91 | (10.5 %) | 0.74 |
Q2 2016 | 339.54 | (22.1 %) | 183.58 | (13.0 %) | 39.61 | (83.3 %) | 0.33 |
Q3 2016 | 257.21 | (16.6 %) | 140.54 | 7.0 % | 4.76 | (83.7 %) | 0.04 |
Q4 2016 | 339.59 | (34.7 %) | 194.16 | (27.1 %) | 143.48 | 1673.8 % | 1.20 |
2016 | 1,258.55 | (26.2 %) | 712.54 | (16.0 %) | 276.76 | (22.5 %) | 2.31 |
Q1 2017 | 393.10 | 22.0 % | 212.58 | 9.4 % | 101.22 | 13.8 % | 0.84 |
Q2 2017 | 304.63 | (10.3 %) | 156.13 | (15.0 %) | 46.56 | 17.5 % | 0.39 |
Q3 2017 | 277.62 | 7.9 % | 128.68 | (8.4 %) | (17.03) | (457.9 %) | (0.14) |
Q4 2017 | 410.69 | 20.9 % | 207.07 | 6.7 % | 66.61 | (53.6 %) | 0.56 |
2017 | 1,386.04 | 10.1 % | 704.46 | (1.1 %) | 197.37 | (28.7 %) | 1.64 |
Q1 2018 | 390.79 | (0.6 %) | 197.32 | (7.2 %) | 55.23 | (45.4 %) | 0.46 |
Q2 2018 | 295.62 | (3.0 %) | 155.28 | (0.5 %) | 22.67 | (51.3 %) | 0.19 |
Q3 2018 | 224.95 | (19.0 %) | 137.89 | 7.2 % | (12.12) | 28.8 % | (0.10) |
Q4 2018 | 600.79 | 46.3 % | 127.79 | (38.3 %) | 19.01 | (71.5 %) | 0.16 |
2018 | 1,503.32 | 8.5 % | 608.52 | (13.6 %) | 76.58 | (61.2 %) | 0.64 |
Period | Revenues | Change | Gross Income | Change | Net Income | Change | EPS(Riyal) |
---|---|---|---|---|---|---|---|
2009 | 950.74 | 9.0 % | 419.59 | 15.6 % | 154.81 | 20.7 % | 1.53 |
2010 | 1,037.64 | 9.1 % | 486.40 | 15.9 % | 176.52 | 14.0 % | 1.47 |
2011 | 1,129.22 | 8.8 % | 560.57 | 15.2 % | 211.44 | 19.8 % | 1.76 |
2012 | 1,183.15 | 4.8 % | 618.56 | 10.3 % | 232.65 | 10.0 % | 1.94 |
2013 | 1,310.50 | 10.8 % | 708.52 | 14.5 % | 266.82 | 14.7 % | 2.22 |
2014 | 1,470.19 | 12.2 % | 794.54 | 12.1 % | 316.85 | 18.8 % | 2.64 |
2015 | 1,705.05 | 16.0 % | 848.60 | 6.8 % | 357.05 | 12.7 % | 2.98 |
2016 | 1,258.55 | (26.2 %) | 712.54 | (16.0 %) | 276.76 | (22.5 %) | 2.31 |
2017 | 1,386.04 | 10.1 % | 704.46 | (1.1 %) | 197.37 | (28.7 %) | 1.64 |
2018 | 1,503.32 | 8.5 % | 608.52 | (13.6 %) | 76.58 | (61.2 %) | 0.64 |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
Q1 2009 | 40.91 % | 16.13 % | 14.83 % |
Q2 2009 | 40.87 % | 16.44 % | 14.89 % |
Q3 2009 | 39.57 % | 15.73 % | 14.07 % |
Q4 2009 | 44.13 % | 18.49 % | 16.63 % |
2009 | 44.13 % | 18.49 % | 16.63 % |
Q1 2010 | 44.45 % | 18.88 % | 16.94 % |
Q2 2010 | 45.32 % | 18.93 % | 17.07 % |
Q3 2010 | 45.73 % | 18.73 % | 16.95 % |
Q4 2010 | 46.88 % | 18.85 % | 17.32 % |
2010 | 46.88 % | 18.85 % | 17.32 % |
Q1 2011 | 48.36 % | 18.99 % | 17.42 % |
Q2 2011 | 48.73 % | 19.12 % | 18.44 % |
Q3 2011 | 49.86 % | 19.99 % | 19.22 % |
Q4 2011 | 49.64 % | 19.57 % | 18.62 % |
2011 | 49.64 % | 19.65 % | 18.72 % |
Q1 2012 | 50.01 % | 19.86 % | 18.73 % |
Q2 2012 | 51.72 % | 20.36 % | 21.31 % |
Q3 2012 | 51.47 % | 20.54 % | 21.21 % |
Q4 2012 | 52.28 % | 19.56 % | 19.66 % |
2012 | 52.28 % | 19.56 % | 19.66 % |
Q1 2013 | 52.36 % | 19.26 % | 19.28 % |
Q2 2013 | 52.98 % | 18.87 % | 20.24 % |
Q3 2013 | 53.58 % | 18.66 % | 20.45 % |
Q4 2013 | 54.06 % | 18.26 % | 20.45 % |
2013 | 54.06 % | 18.16 % | 20.36 % |
Q1 2014 | 53.95 % | 17.92 % | 21.86 % |
Q2 2014 | 53.91 % | 17.74 % | 20.28 % |
Q3 2014 | 53.39 % | 16.79 % | 19.84 % |
Q4 2014 | 54.03 % | 18.15 % | 21.50 % |
2014 | 54.04 % | 18.15 % | 21.55 % |
Q1 2015 | 54.34 % | 18.90 % | 21.67 % |
Q2 2015 | 53.23 % | 18.31 % | 20.04 % |
Q3 2015 | 51.63 % | 17.40 % | 19.05 % |
Q4 2015 | 49.19 % | 17.17 % | 19.11 % |
2015 | 49.77 % | 16.85 % | 19.02 % |
Q1 2016 | 50.60 % | 15.90 % | 18.80 % |
Q2 2016 | 52.04 % | 15.52 % | 16.88 % |
Q3 2016 | 54.52 % | 15.09 % | 15.79 % |
Q4 2016 | 56.62 % | 10.25 % | 5.68 % |
2016 | 56.62 % | 10.25 % | 5.68 % |
Q1 2017 | 54.97 % | 9.67 % | 3.99 % |
Q2 2017 | 54.34 % | 11.85 % | 4.64 % |
Q3 2017 | 52.59 % | 11.94 % | 2.91 % |
Q4 2017 | 50.83 % | 14.96 % | 9.94 % |
2017 | 50.83 % | 14.96 % | 9.94 % |
Q1 2018 | 49.81 % | 16.45 % | 9.97 % |
Q2 2018 | 50.07 % | 14.49 % | 8.30 % |
Q3 2018 | 52.76 % | 15.07 % | 9.00 % |
Q4 2018 | 40.89 % | 5.68 % | 5.61 % |
2018 | 40.48 % | 4.92 % | 5.09 % |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
2009 | 44.13 % | 18.49 % | 16.63 % |
2010 | 46.88 % | 18.85 % | 17.32 % |
2011 | 49.64 % | 19.65 % | 18.72 % |
2012 | 52.28 % | 19.56 % | 19.66 % |
2013 | 54.06 % | 18.16 % | 20.36 % |
2014 | 54.04 % | 18.15 % | 21.55 % |
2015 | 49.77 % | 16.85 % | 19.02 % |
2016 | 56.62 % | 10.25 % | 5.68 % |
2017 | 50.83 % | 14.96 % | 9.94 % |
2018 | 40.48 % | 4.92 % | 5.09 % |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
Q1 2009 | 42.10 % | 20.70 % | 16.62 % |
Q2 2009 | 35.60 % | 10.54 % | 16.51 % |
Q3 2009 | 42.35 % | 15.37 % | 9.25 % |
Q4 2009 | 53.64 % | 24.60 % | 21.04 % |
Q1 2010 | 43.34 % | 21.92 % | 17.70 % |
Q2 2010 | 39.83 % | 11.52 % | 17.08 % |
Q3 2010 | 44.87 % | 14.68 % | 9.44 % |
Q4 2010 | 56.68 % | 24.50 % | 21.92 % |
Q1 2011 | 49.00 % | 22.74 % | 18.13 % |
Q2 2011 | 42.32 % | 13.00 % | 20.80 % |
Q3 2011 | 51.02 % | 19.57 % | 14.22 % |
Q4 2011 | 55.00 % | 22.56 % | 19.71 % |
Q1 2012 | 50.54 % | 23.32 % | 18.62 % |
Q2 2012 | 49.16 % | 14.95 % | 31.45 % |
Q3 2012 | 49.82 % | 20.53 % | 14.22 % |
Q4 2012 | 57.70 % | 19.47 % | 14.68 % |
Q1 2013 | 51.09 % | 21.68 % | 17.48 % |
Q2 2013 | 52.04 % | 14.20 % | 33.03 % |
Q3 2013 | 53.22 % | 19.34 % | 15.34 % |
Q4 2013 | 59.20 % | 18.05 % | 14.92 % |
Q1 2014 | 51.02 % | 20.19 % | 22.50 % |
Q2 2014 | 52.04 % | 13.80 % | 26.33 % |
Q3 2014 | 50.54 % | 13.97 % | 13.79 % |
Q4 2014 | 60.73 % | 22.54 % | 21.18 % |
Q1 2015 | 52.26 % | 22.70 % | 23.00 % |
Q2 2015 | 48.40 % | 12.42 % | 19.81 % |
Q3 2015 | 42.60 % | 9.85 % | 9.46 % |
Q4 2015 | 51.19 % | 20.88 % | 21.02 % |
Q1 2016 | 60.29 % | 18.36 % | 22.80 % |
Q2 2016 | 54.07 % | 9.77 % | 11.67 % |
Q3 2016 | 54.64 % | 6.30 % | 1.85 % |
Q4 2016 | 57.18 % | 6.04 % | (13.65 %) |
Q1 2017 | 54.08 % | 14.94 % | 14.01 % |
Q2 2017 | 51.25 % | 19.02 % | 15.29 % |
Q3 2017 | 46.35 % | 7.17 % | (6.13 %) |
Q4 2017 | 50.42 % | 17.25 % | 12.96 % |
Q1 2018 | 50.49 % | 20.19 % | 14.13 % |
Q2 2018 | 52.53 % | 9.98 % | 7.67 % |
Q3 2018 | 61.30 % | 8.88 % | (5.39 %) |
Q4 2018 | 21.27 % | (7.08 %) | 3.16 % |
Period | Shares Outstanding (M) | EPS (Riyal) | Adjusted EPS (Riyal) | Book Value (BV) |
---|---|---|---|---|
Q1 2009 | 101.51 | 1.28 | 1.33 | 14.17 |
Q2 2009 | 101.51 | 1.32 | 1.36 | 17.62 |
Q3 2009 | 101.51 | 1.32 | 1.32 | 19.72 |
Q4 2009 | 101.51 | 1.53 | 1.56 | 21.46 |
Q1 2010 | 120.00 | 1.31 | 1.36 | 22.04 |
Q2 2010 | 120.00 | 1.36 | 1.41 | 19.98 |
Q3 2010 | 120.00 | 1.37 | 1.43 | 21.69 |
Q4 2010 | 120.00 | 1.47 | 1.50 | 24.48 |
Q1 2011 | 120.00 | 1.47 | 1.47 | 25.41 |
Q2 2011 | 120.00 | 1.62 | 1.62 | 27.29 |
Q3 2011 | 120.00 | 1.72 | 1.72 | 25.92 |
Q4 2011 | 120.00 | 1.75 | 1.75 | 26.50 |
Q1 2012 | 120.00 | 1.84 | 1.84 | 30.26 |
Q2 2012 | 120.00 | 2.09 | 2.09 | 25.75 |
Q3 2012 | 120.00 | 2.11 | 2.11 | 26.24 |
Q4 2012 | 120.00 | 1.94 | 1.94 | 25.28 |
Q1 2013 | 120.00 | 1.99 | 1.99 | 27.18 |
Q2 2013 | 120.00 | 2.19 | 2.19 | 26.14 |
Q3 2013 | 120.00 | 2.21 | 2.21 | 27.35 |
Q4 2013 | 120.00 | 2.23 | 2.23 | 32.18 |
Q1 2014 | 120.00 | 2.47 | 2.47 | 32.96 |
Q2 2014 | 120.00 | 2.33 | 2.33 | 33.21 |
Q3 2014 | 120.00 | 2.35 | 2.35 | 35.74 |
Q4 2014 | 120.00 | 2.64 | 2.64 | 28.75 |
Q1 2015 | 120.00 | 2.71 | 2.71 | 27.84 |
Q2 2015 | 120.00 | 3.87 | 2.61 | 28.72 |
Q3 2015 | 120.00 | 3.81 | 2.55 | 24.87 |
Q4 2015 | 120.00 | 2.98 | 2.70 | 22.17 |
Q1 2016 | 120.00 | 2.89 | 2.49 | 20.84 |
Q2 2016 | 120.00 | 1.24 | 2.10 | 20.49 |
Q3 2016 | 120.00 | 1.03 | 1.89 | 20.40 |
Q4 2016 | 120.00 | 2.31 | 0.60 | 22.59 |
Q1 2017 | 120.00 | 2.41 | 0.44 | 23.27 |
Q2 2017 | 120.00 | 2.47 | 0.50 | 21.52 |
Q3 2017 | 120.00 | 2.29 | 0.32 | 22.01 |
Q4 2017 | 120.00 | 1.64 | 1.15 | 22.78 |
Q1 2018 | 120.00 | 1.26 | 1.15 | 25.04 |
Q2 2018 | 120.00 | 1.06 | 0.95 | 25.74 |
Q3 2018 | 120.00 | 1.10 | 0.99 | 24.32 |
Q4 2018 | 120.00 | 0.71 | 0.71 | 21.17 |
Period | Shares Outstanding (M) | EPS (Riyal) | Adjusted EPS (Riyal) | Book Value (BV) |
---|---|---|---|---|
2009 | 101.51 | 1.53 | 1.56 | 21.46 |
2010 | 120.00 | 1.47 | 1.50 | 24.48 |
2011 | 120.00 | 1.76 | 1.76 | 26.50 |
2012 | 120.00 | 1.94 | 1.94 | 25.28 |
2013 | 120.00 | 2.22 | 2.22 | 32.18 |
2014 | 120.00 | 2.64 | 2.64 | 28.75 |
2015 | 120.00 | 2.98 | 2.70 | 22.17 |
2016 | 120.00 | 2.31 | 0.60 | 22.59 |
2017 | 120.00 | 1.64 | 1.15 | 22.78 |
2018 | 120.00 | 0.64 | 0.64 | 21.17 |
Period | P/E | Adjusted P/E | Price/book |
---|---|---|---|
Q1 2009 | 14.92 | 14.39 | 1.35 |
Q2 2009 | 17.20 | 16.65 | 1.28 |
Q3 2009 | 18.29 | 18.26 | 1.22 |
Q4 2009 | 15.25 | 14.94 | 1.08 |
Q1 2010 | 16.69 | 16.04 | 0.99 |
Q2 2010 | 14.70 | 14.15 | 1.00 |
Q3 2010 | 14.64 | 14.10 | 0.93 |
Q4 2010 | 15.82 | 15.53 | 0.95 |
Q1 2011 | 17.65 | 17.65 | 1.02 |
Q2 2011 | 15.68 | 15.68 | 0.93 |
Q3 2011 | 14.41 | 14.41 | 0.96 |
Q4 2011 | 15.03 | 15.03 | 0.99 |
Q1 2012 | 17.92 | 17.92 | 1.09 |
Q2 2012 | 12.56 | 12.56 | 1.02 |
Q3 2012 | 13.70 | 13.70 | 1.10 |
Q4 2012 | 14.74 | 14.74 | 1.13 |
Q1 2013 | 13.60 | 13.60 | 1.00 |
Q2 2013 | 15.51 | 15.51 | 1.30 |
Q3 2013 | 15.70 | 15.70 | 1.27 |
Q4 2013 | 19.02 | 19.02 | 1.32 |
Q1 2014 | 19.07 | 19.07 | 1.43 |
Q2 2014 | 19.29 | 19.29 | 1.36 |
Q3 2014 | 21.41 | 21.41 | 1.41 |
Q4 2014 | 12.89 | 12.89 | 1.18 |
Q1 2015 | 14.78 | 14.78 | 1.44 |
Q2 2015 | 11.59 | 17.18 | 1.56 |
Q3 2015 | 9.46 | 14.14 | 1.45 |
Q4 2015 | 11.16 | 12.29 | 1.50 |
Q1 2016 | 11.15 | 12.96 | 1.55 |
Q2 2016 | 29.96 | 17.69 | 1.81 |
Q3 2016 | 30.18 | 16.49 | 1.53 |
Q4 2016 | 17.72 | 68.63 | 1.81 |
Q1 2017 | 15.03 | 81.82 | 1.56 |
Q2 2017 | 14.32 | 70.59 | 1.64 |
Q3 2017 | 14.43 | More than 100 | 1.50 |
Q4 2017 | 18.25 | 26.14 | 1.32 |
Q1 2018 | 24.34 | 26.70 | 1.23 |
Q2 2018 | 30.03 | 33.56 | 1.24 |
Q3 2018 | 28.37 | 31.57 | 1.29 |
Q4 2018 | 41.61 | 41.61 | 1.39 |
Period | P/E | Adjusted P/E | Price/book |
---|---|---|---|
2009 | 15.25 | 14.94 | 1.08 |
2010 | 15.82 | 15.53 | 0.95 |
2011 | 14.95 | 14.95 | 0.99 |
2012 | 14.74 | 14.74 | 1.13 |
2013 | 19.11 | 19.11 | 1.32 |
2014 | 12.89 | 12.89 | 1.18 |
2015 | 11.16 | 12.29 | 1.50 |
2016 | 17.72 | 68.63 | 1.81 |
2017 | 18.25 | 26.14 | 1.32 |
2018 | 46.07 | 46.07 | 1.39 |
Q3 2018
2018
Period | Pharmaceutical Manufacturing | healthy services and other | Trading & Distribution Services | Contract manufacturing arrangements | Medical & Pharmaceutical production segment | Investment activity | Eliminations |
---|---|---|---|---|---|---|---|
Q1 2009 | - | - | - | - | 257.88 | - | - |
Q2 2009 | - | - | - | - | 229.00 | - | - |
Q3 2009 | - | - | - | - | 171.15 | - | - |
Q4 2009 | - | - | - | - | 292.71 | - | - |
Q1 2010 | - | - | - | - | 274.33 | - | - |
Q2 2010 | - | - | - | - | 252.34 | - | - |
Q3 2010 | - | - | - | - | 191.41 | - | - |
Q4 2010 | - | - | - | - | 319.57 | - | - |
Q1 2011 | - | - | - | - | 252.08 | - | - |
Q2 2011 | - | - | - | - | 292.08 | - | - |
Q3 2011 | - | - | - | - | 209.24 | - | - |
Q4 2011 | - | - | - | - | 375.82 | - | - |
Q1 2012 | - | - | - | - | 303.14 | - | - |
Q2 2012 | - | - | - | - | 286.65 | - | - |
Q3 2012 | - | - | - | - | 227.40 | - | - |
Q4 2012 | - | - | - | - | 365.97 | - | - |
Q1 2013 | - | - | - | - | 361.37 | - | - |
Q2 2013 | - | - | - | - | 344.22 | - | - |
Q3 2013 | - | - | - | - | 222.91 | - | - |
Q4 2013 | - | - | - | - | 382.01 | - | - |
Q1 2014 | - | - | - | - | 405.21 | - | - |
Q2 2014 | - | - | - | - | 374.14 | - | - |
Q3 2014 | - | - | - | - | 266.02 | - | - |
Q4 2014 | - | - | - | - | 427.82 | - | - |
Q1 2015 | - | - | - | - | 432.29 | 14.84 | - |
Q2 2015 | - | - | - | - | 436.99 | 195.93 | - |
Q3 2015 | - | - | - | - | 308.38 | 9.55 | - |
Q4 2015 | - | - | - | - | 529.24 | - | - |
Q1 2016 | - | - | - | - | 513.97 | 25.27 | - |
Q2 2016 | - | - | - | - | 494.92 | 9.41 | - |
Q3 2016 | - | - | - | - | 100.39 | 6.23 | - |
Q4 2016 | - | - | - | - | 401.35 | 247.84 | - |
Q1 2017 | - | - | - | - | 446.00 | 50.90 | (51.45) |
Q2 2017 | - | - | - | - | 350.01 | 1.39 | (43.30) |
Q3 2017 | - | - | - | - | 317.29 | 4.01 | (36.78) |
Q4 2017 | - | - | - | - | 486.15 | - | (54.74) |
Q1 2018 | - | - | - | - | 450.19 | 7.00 | (57.49) |
Q3 2018 | 172.41 | 34.26 | 1.75 | 16.54 | - | - | - |
Period | Pharmaceutical Manufacturing | healthy services and other | Trading & Distribution Services | Contract manufacturing arrangements | Medical & Pharmaceutical production segment | Investment activity | Eliminations |
---|---|---|---|---|---|---|---|
2009 | - | - | - | - | 950.74 | - | - |
2010 | - | - | - | - | 1,037.64 | - | - |
2011 | - | - | - | - | 1,129.22 | - | - |
2012 | - | - | - | - | 1,183.15 | - | - |
2013 | - | - | - | - | 1,310.50 | - | - |
2014 | - | - | - | - | 1,470.19 | - | - |
2015 | - | - | - | - | 1,706.80 | 115.14 | - |
2016 | - | - | - | - | 1,510.63 | 288.74 | (244.41) |
2017 | - | - | - | - | 1,599.45 | 61.92 | (186.28) |
2018 | 1,414.72 | 78.37 | 5.02 | 5.22 | - | - | - |
Current | |
Market Cap (M Riyal) | 3,744.00 |
Enterprise Value (EV) (M) | 4,825.48 |
Shares Outstanding ((M)) | 120.00 |
EPS ( Riyal) (TTM) | (0.27) |
Book Value (BV) ( Riyal) | 12.89 |
Par Value ( Riyal) | 10.00 |
Adjusted P/E (Last12) | Neg |
P/E (TTM) | NEG |
Price/book | 2.42 |
Return on Average Assets (%) (TTM) | (0.76 ) |
Return on Average Equity (%) (TTM) | (2.09 ) |
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}